Dawnrays Pharmaceutical (Holdings) Dirección
Dirección controles de criterios 2/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Liwei Yu
Chief Executive Officer (CEO)
n/a
Compensación total
| Porcentaje del salario del CEO | n/a |
| Permanencia del CEO | less than a year |
| Participación del CEO | n/a |
| Permanencia media de la dirección | 18.2yrs |
| Promedio de permanencia en la Junta Directiva | 16.5yrs |
Actualizaciones recientes de la dirección
Recent updates
Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Earnings Might Not Be As Promising As They Seem
Sep 21
Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.015
Sep 11Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.065
May 25Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of CN¥0.065
Apr 22Dawnrays Pharmaceutical (Holdings) (HKG:2348) Has Announced A Dividend Of CN¥0.065
Apr 08Dawnrays Pharmaceutical (Holdings) (HKG:2348) Is Due To Pay A Dividend Of CN¥0.065
Mar 25Dawnrays Pharmaceutical (Holdings) (HKG:2348) Has Announced A Dividend Of CN¥0.015
Aug 30Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Shareholders Will Receive A Bigger Dividend Than Last Year
May 26Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of CN¥0.073
Apr 04Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.015
Sep 19Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Solid Profits Have Weak Fundamentals
Sep 22Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of HK$0.015
Sep 12Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be HK$0.015
Aug 29Here's How We Evaluate Dawnrays Pharmaceutical (Holdings) Limited's (HKG:2348) Dividend
Feb 28Would Shareholders Who Purchased Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Stock Five Years Be Happy With The Share price Today?
Feb 07
Yung Lai Hung Is The Co-Founder & Executive Director of Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348) And They Just Picked Up 34% More Shares
Jan 14Dawnrays Pharmaceutical (Holdings) Limited's (HKG:2348) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Dec 22What Kind Of Investors Own Most Of Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)?
Dec 09Three Things You Should Check Before Buying Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348) For Its Dividend
Nov 23CEO
Liwei Yu (54 yo)
less than a year
Permanencia
Ms. Liwei Yu is Chief Executive Officer of Dawnrays Pharmaceutical (Holdings) Limited from September 13, 2024. Ms. Yu is the Chief Human Resources Officer of the Group and fully responsible for the human r...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 22.1yrs | CN¥1.05m | 7.15% HK$ 132.1m | |
| Co-Founder & Executive Director | 29.8yrs | CN¥672.00k | 0.13% HK$ 2.3m | |
| Chief Executive Officer | less than a year | sin datos | sin datos | |
| Chief Financial Officer | 6.6yrs | sin datos | sin datos | |
| Company Secretary | no data | sin datos | sin datos |
18.2yrs
Permanencia media
60yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de 2348 es experimentado (18.2 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 22.1yrs | CN¥1.05m | 7.15% HK$ 132.1m | |
| Co-Founder & Executive Director | 22.1yrs | CN¥672.00k | 0.13% HK$ 2.3m | |
| Independent Non-Executive Director | 9.4yrs | CN¥326.00k | sin datos | |
| Non-Executive Director | 19yrs | CN¥271.00k | sin datos | |
| Independent Non-Executive Director | 14.1yrs | CN¥326.00k | sin datos | |
| Independent Non-Executive Director | 6.5yrs | CN¥326.00k | sin datos |
16.5yrs
Permanencia media
60.5yo
Promedio de edad
Junta con experiencia: Los miembros de la junta directiva de 2348 son experimentados ( 16.5 años antigüedad media).